Cover
New Biologics Course at ITE
Pulse
ITE Sets Double Records
in Single Day
So Young, So Promising
Smart Solutions
Valued Certification
Disbursing Care
Buzz
Our Distinguished Visitors
I Can See Clearly Now
Real Cars for Authentic
Learning
Clowning Around
Stars
Teachers with Passion
Advertisement
French Fare
Snapshot
Project Runway
Behind The Scenes
Meet the Editorial Committee
 
 
 

WITH approximately S$2.8 billion worth of investments within the last four years, Singapore’s fledgling biologics manufacturing industry is set to see meteoric growth. GCE ‘N’ and ‘O’ school leavers who aspire to carve a career in this high-value field will now have an additional platform to do so, with the introduction of a new full-time Nitec in Chemical Process Technology (Biologics) course at ITE in January 2010.

Mr Bob Tan, Chairman of ITE, announced the new course on 25 November 2009, following a visit by the ITE Board of Governors to GlaxoSmithKline Biologicals. Mr Tan said that the new course will meet critical manpower needs in the burgeoning biomedical sciences industry.

Industry-relevant Curriculum
Figures from the Singapore Economic Development Board indicate that the biomedical sciences manufacturing sector generated a manufacturing output of S$19 billion in 2008. The industry currently employs more than 12,000 employees, with the value-added per worker estimated at S$0.8 million.

Explaining the rationale behind the new two-year full-time Nitec in Chemical Process Technology (Biologics) course, Mr Bruce Poh, Director & CEO, ITE, said: “ITE works closely with key industry players in developing the course curriculum and skill standards that would match the needs of the industry. Students will undergo training to equip them with broad-based skills and knowledge to operate and maintain biologics production equipment and facilities, monitor and control processes to produce therapeutic products from biological systems in a bio-pharmaceutical environment. This would ensure the supply of well-trained process or plant operations personnel for the Biologics sector.”

Strong Industry Endorsement for Programme
The new course also got the nod from industry players. Mr Vincent Hingot, Site Director of GlaxoSmithKline Biologicals, said: “Singapore is still relatively new in the biologics and bio-pharmaceuticals industry. As the pool of ready talent is small today, much investment and efforts in the public and private sectors are needed to develop Singapore’s capabilities in these areas. With the Government’s strong support and commitment to this sector, we see increasingly more reputable pharmaceutical firms making Singapore a base for their biologics operations in the region.”

 
                   
     
Ms Linda Brown
Deputy Vice Chancellor (TAFE), Swinburne University, Australia
Mr Bruce Poh
Director & CEO, ITE
  Mr Richard R Magnus
Chairman, Temasek Cares
“ITE was the best college among over 250 colleges that I have visited worldwide.” “At ITE, our ardent support towards
entrepreneurial development has yielded
positive results in developing a strong culture of entrepreneurship.”

“I am glad that we are partnering ITE to nurture young people through education and training for employability skills.”

 
  Read more   Read more   Read more
       
   
+ Past issues of infinITE   + ITE College Central   + Contact
Newsletter of the Ministry of Education
 
+ ITE Corporate Profile + ITE College East + Eyecatcher
Newsletter of the Civil Service Club
+ ITE Advantage
ITE’s new Strategic Plan
+ ITE College West    
+ Employers' Services
Find out how ITE can work hand in hand with you, as an employer
+ ITE Alumni Association News
Are you an ITE graduate? Find out what the ITE Alumni Association has to offer
   
+ Just for Schools
Find out more about ITE's linkages and activities with secondary schools
Feedback or suggestions? We'd love to hear from you.   © 2008 Institute of Technical Education, Singapore